Insights on multiple myeloma treatment strategies
Keywords: 
Myeloma
Treatment Strategies
Therapies
Biomarkers
Delay progression
Issue Date: 
2018
Publisher: 
Ovid Technologies (Wolters Kluwer Health)
ISSN: 
2572-9241
Note: 
This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Citation: 
Mateos, M.V. (María Victoria); Ludwig, H. (Heinz); Bazarbachi, A. (Ali); et al. "Insights on multiple myeloma treatment strategies". HemaSphere. 3 (1), 2018, e163
Abstract
The introduction of new agents and management strategies over the past decade has resulted in a major step change in treatment outcomes with deepening responses and increased survival for patients with multiple myeloma. In daily clinical practice, healthcare professionals are now faced with challenges including, optimal treatment sequencing and changing treatment goals. In light of this, a group of experts met to discuss diagnostic and treatment guidelines, examine current clinical practice, and consider how new clinical trial data may be integrated into the management of multiple myeloma in the future.

Files in This Item:
Thumbnail
File
Insights_on_Multiple_Myeloma_Treatment_Strategies.7.pdf
Description
Size
4.42 MB
Format
Adobe PDF


Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.